Mortality and incidence of second cancers following treatment for testicular cancer

por Robinson, D, Møller, H, Horwich, A
Publicado 2007

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised pha...

por Bajetta, E, Di Bartolomeo, M, Buzzoni, R, Mariani, L, Zilembo, N, Ferrario, E, Lo Vullo, S, Aitini, E, Isa, L, Barone, C, Jacobelli, S, Recaldin, E, Pinotti, G, Iop, A
Publicado 2007

Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK

por Camidge, D R, Stockton, D L, Frame, S, Wood, R, Bain, M, Bateman, D N
Publicado 2007

Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels

por Giovannetti, E, Backus, H H J, Wouters, D, Ferreira, C G, van Houten, V M M, Brakenhoff, R H, Poupon, M-F, Azzarello, A, Pinedo, H M, Peters, G J
Publicado 2007

Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site

por Fedida, S, Fishman, D, Suzlovich, Z, Argov, S, Friger, M, Oren, L, Segal, S, Sion-Vardy, N
Publicado 2007

Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review

por Hind, D, Wyld, L, Reed, M W
Publicado 2007

In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol

por Chander, S K, Foster, P A, Leese, M P, Newman, S P, Potter, B V L, Purohit, A, Reed, M J
Publicado 2007

Comorbidity and survival of Danish breast cancer patients from 1995 to 2005

por Cronin-Fenton, D P, Nørgaard, M, Jacobsen, J, Garne, J P, Ewertz, M, Lash, T L, Sørensen, H T
Publicado 2007

Benign prostatic hyperplasia and subsequent risk of bladder cancer

por Kang, D, Chokkalingam, A P, Gridley, G, Nyren, O, Johansson, J E, Adami, H O, Silverman, D, Hsing, A W
Publicado 2007

Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours

por Marrache, F, Vullierme, M P, Roy, C, Assoued, Y El, Couvelard, A, O'Toole, D, Mitry, E, Hentic, O, Hammel, P, Lévy, P, Ravaud, P, Rougier, P, Ruszniewski, P
Publicado 2007

Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model

por Niedergethmann, M, Alves, F, Neff, J K, Heidrich, B, Aramin, N, Li, L, Pilarsky, C, Grützmann, R, Allgayer, H, Post, S, Gretz, N
Publicado 2007

R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies

por Arts, J, Angibaud, P, Mariën, A, Floren, W, Janssens, B, King, P, van Dun, J, Janssen, L, Geerts, T, Tuman, R W, Johnson, D L, Andries, L, Jung, M, Janicot, M, van Emelen, K
Publicado 2007

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens

por Krasner, C N, McMeekin, D S, Chan, S, Braly, P S, Renshaw, F G, Kaye, S, Provencher, D M, Campos, S, Gore, M E
Publicado 2007

Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma

por Lindsey, J C, Lusher, M E, Anderton, J A, Gilbertson, R J, Ellison, D W, Clifford, S C
Publicado 2007

Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion

por Ma, P C, Tretiakova, M S, Nallasura, V, Jagadeeswaran, R, Husain, A N, Salgia, R
Publicado 2007

The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care

por Emery, J, Morris, H, Goodchild, R, Fanshawe, T, Prevost, A T, Bobrow, M, Kinmonth, A L
Publicado 2007

The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials

por Marchetti, S, Schellens, J H M
Publicado 2007

In vitro evaluation of cancer-specific NF-κB-CEA enhancer–promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines

por Guo, X, Evans, T R J, Somanath, S, Armesilla, A L, Darling, J L, Schatzlein, A, Cassidy, J, Wang, W
Publicado 2007

[(18)F]2-Fluoro-2-deoxy-D-glucose incorporation by AGS gastric adenocarcinoma cells in vitro during response to epirubicin, cisplatin and 5-fluorouracil

por Suttie, S A, Park, K G M, Smith, T A D
Publicado 2007

Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules

por Li, K M, Rivory, L P, Clarke, S J
Publicado 2007